Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain.

The research studied the effects of Bovine papillomavirus type 1 oncoprotein E5 on equine cells, demonstrating that it hampers their immune responses by inhibiting their major histocompatibility complex class I (MHC I).

Introduction

The research focused on how Bovine papillomavirus type 1, a causal agent in equine sarcoids, interacts with equine cells. It centered on the behavior of the E5 oncoprotein, which is often expressed in sarcoids and associated cell lines. The researchers specifically wanted to understand if E5 has similar effects in equine cells as observed in bovine cells.

Methodology

• The E5 open reading frame, essentially the part of the gene encoding the E5 protein, was introduced into the equine cell line known as EqPalF which are fetal equine fibroblasts.
• The researchers discovered that, as in bovine fibroblasts, E5 could not independently transform the equine cells. Instead, an immortalizing gene (human telomerase or hTERT/hT) was needed for the cells to outlive the selection process.
• Once immortalized, the transformed cells exhibited morphological changes, becoming elongated and capable of forming foci, concentrated cellular structures or functions.

Observations

• Notably, the presence of the E5 gene inhibited the production and function of MHC I in these equine cells.
• Impediment of MHC I occured at the transcription stage, restricting the production of its heavy chain. This resulted in the retention of the MHC I complex within the Golgi apparatus, a cellular structure involved in the processing and transport of proteins, and prevented it from reaching the cell surface.
• This means that MHC I, a crucial component in immune response, was inoperable in these cells, potentially weakening their ability to clear out tumour cells.

Conclusion

• Based on their findings, the researchers concluded that E5 does play a significant role in equine cell transformation and sarcoid induction.
• The protein is a potential major cause of MHC I downregulation, which in turn might lead to poor immune clearance of tumour cells, similar to what is observed in bovine cells and tumours.